The global Psoriatic Arthritis (PsA) Treatment Market Size is anticipated to approach US$ 10.3 billion by 2022. The market is estimated to reach US$ 15.6 billion by 2028, with a 7.1% CAGR. The Psoriatic Arthritis (PsA) Treatment Market is expected to develop at a 7.1% CAGR between 2022 and 2028, up from a 6.7% CAGR …
Category Archives: Healthcare Trends
Generic Oncology Drugs Market is likely to register CAGR of 6% through 2028
The global Generic Oncology Drugs Market Demand is predicted to increase at a 6% CAGR between 2022 and 2028, reaching more than US$ 34.8 billion by the end of 2028. Individuals’ increasing proclivity to smoke and tobacco intake is the leading cause of cancer. Sedentary lifestyle, genetic causes, virus infections, carcinogens, and a high consumption …
Continue reading “Generic Oncology Drugs Market is likely to register CAGR of 6% through 2028”
Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033- FMI Study
The global Eosinophilic Granulomatosis With Polyangiitis Treatment Market is currently valued at US$ 173.8 Million in 2023 and is anticipated to expand at a CAGR of 5.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 288.5 Million by 2033. The growing occurrences of churg strauss syndrome and other allergic reactions and …
Chronic Refractory Cough Treatment Market | Aurobindo Pharma Ltd, Mylan N.V., GSK Plc., Hikma Pharmaceuticals Plc | By 2033
The Chronic Refractory Cough Treatment Market is anticipated to be worth US$ 9.2 billion in 2023 and US$ 17.1 billion by 2033, growing at a CAGR of 6.39%. The market for treatments for refractory chronic cough is driven by the rising prevalence of refractory chronic cough worldwide. The size of the market would increase, enabling pharmaceutical companies …
Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is projected to exhibit a CAGR of 4.2% from 2023 to 2033, a valuation of US$ 7.29 billion
At a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033, the Diamond-Blackfan Anemia (DBAAASE) Syndrome Therapeutics Market is expected to surpass an amazing US$ 4.8 billion in 2023. By 2033, the market for therapeutics for Diamond-Blackfan Anaemia (DBAAASE) Syndrome is anticipated to be worth US$7.29 billion. Due to the fact that 90% …
Chronic Granulomatous Disease (CGD) Management Market | Bellicum Pharmaceuticals, Inc, Pfizer Inc, Hoffmann-La Roche Ltd, Novartis AG | By 2033
According to Future Market Insights, the Chronic Granulomatous Disease (CGD) Management Market is anticipated to expand at a rate of 4.9% CAGR between 2023 and 2033. The management of Chronic Granulomatous Disease (CGD) is anticipated to reach a market valuation of US$2.11 billion by the year 2033. Due to a number of factors, including the …
Arthrogryposis Management Market is expected to accumulate a market value of US$ 447.41 Million by registering a CAGR of 6%
The Global Arthrogryposis Management Market is expected to reach a market value of US$ 250 million in 2023 and a market value of US$ 447.41 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Arthrogryposis Management market grew at a CAGR of 4%. With the latest insights and statistics from the biggest pharmaceutical and healthcare device …
Abetalipoproteinemia Management Market is projected to reach US$ 341 million by 2033, growing at a CAGR of 8.78 %
The Abetalipoproteinemia Management Market is anticipated to expand from its current estimated value of US$ 147 million in 2023 to US$ 341 million by 2033, at a CAGR of 8.78%. The growing popularity of imaging tests like hepatic scans or ultrasonography to evaluate changes in fatty liver, as well as magnetic resonance imaging (MRI) of …
Biosensors Market in South Korea is expected to reach a valuation of US$ 1.6 billion by 2032 Growing at a CAGR of 10.3%
According to Future Market Insights newly released Biosensors Market analysis report, the global market size of the Biosensors Market in 2022 will be US$ 24.5 Billion. The projected market growth is expected to be significantly higher than the historical growth, with a CAGR of 9.5% from 2023 to 2033. Medical biosensors are expected to be the most profitable segment, …
Global Klinefelter Syndrome Therapeutics Market to reach US$ 1.85 Billion by 2033, Testosterone Replacement Therapy to be Most Preferred: FMI Report
The global Klinefelter Syndrome Therapeutics Market is expected to surge at a CAGR of 5% from 2023 to 2033, expected to reach a valuation of US$ 1.85 Billion, up from US$ 1.14 Billion in 2023, concludes a recently published Future Market Insights report. Because the disease is difficult to diagnose due to unidentifiable symptoms and …